Cargando…

The effect of Co-Q10 on allergic rhinitis and allergic asthma

BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Qixue, Meng, Wei, Athari, Seyyed Shamsadin, Wang, Renzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980733/
https://www.ncbi.nlm.nih.gov/pubmed/33743807
http://dx.doi.org/10.1186/s13223-021-00534-5
_version_ 1783667483660517376
author Du, Qixue
Meng, Wei
Athari, Seyyed Shamsadin
Wang, Renzhong
author_facet Du, Qixue
Meng, Wei
Athari, Seyyed Shamsadin
Wang, Renzhong
author_sort Du, Qixue
collection PubMed
description BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria can control asthma and allergic rhinitis symptoms. In the present study, we determined that the CoQ10-induced anti-allergic effects were mediated by up-regulation of Nrf2. METHODS: Animal models of allergic rhinitis and allergic asthma were produced and treated with Co-Q10, Co-Q10 and O-3, Co-Q10 and Mg-S. Bronchoalveolar lavage fluid was collected from animal models, and IL-4, 5, 13, INF-y, Eicosanoids, IgE, EPO, and histamine production were measured. Also, COX-2, CCL24, CCL11, Nrf2, Eotaxin, Cytb, COX1 and ND1 genes expressions and histopathology were studied. BALf's cells were collected by tracheostomy and used in slide producing by cytospine. Cytokines, Eicosanoids, IgE, EPO, and histamine were measured by ELISA method. Gene expression was done by Real-time PCR. RESULTS: Co-Q10 with two supplementation (Mg-S and O-3) modulate MRC, BALf eosinophils, eosinophilic inflammation related genes (eotaxin, CCL11 and CCL24), peribronchial and perivascular inflammation, EPO, type 2 cytokines (IL-4, 5 and 13), IgE, histamine, Cyc-LT and LTB4 as main allergic bio-factors. Importantly, Co-Q10 treatment increased Nrf2 expression and Nrf2 induced antioxidant genes, glutathione redox and inhibited inflammation, oxidative stress injury, Th2 cytokines production and attenuated allergic inflammatory responses. CONCLUSION: Nrf2 is activated in response to allergen, induces resistance against the rhinitis and asthma development and plays an essential role in broncho-protection. Co-Q10 increases the Nrf2 expression and the Nrf2 over-expression has strong effect in control of type2 cytokines, allergic mediators and inflammatory factors that lead to harnessing of allergy and asthma. GRAPHIC ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-7980733
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79807332021-03-22 The effect of Co-Q10 on allergic rhinitis and allergic asthma Du, Qixue Meng, Wei Athari, Seyyed Shamsadin Wang, Renzhong Allergy Asthma Clin Immunol Research BACKGROUND: Allergic asthma is an inflammatory disease resulting from continued or intermittent allergen exposure, and allergic rhinitis can be trigger of asthma. The main mechanism of these disease is allergic reaction and immune response dysregulation. Co-Q10 is an enzyme cofactor in mitochondria can control asthma and allergic rhinitis symptoms. In the present study, we determined that the CoQ10-induced anti-allergic effects were mediated by up-regulation of Nrf2. METHODS: Animal models of allergic rhinitis and allergic asthma were produced and treated with Co-Q10, Co-Q10 and O-3, Co-Q10 and Mg-S. Bronchoalveolar lavage fluid was collected from animal models, and IL-4, 5, 13, INF-y, Eicosanoids, IgE, EPO, and histamine production were measured. Also, COX-2, CCL24, CCL11, Nrf2, Eotaxin, Cytb, COX1 and ND1 genes expressions and histopathology were studied. BALf's cells were collected by tracheostomy and used in slide producing by cytospine. Cytokines, Eicosanoids, IgE, EPO, and histamine were measured by ELISA method. Gene expression was done by Real-time PCR. RESULTS: Co-Q10 with two supplementation (Mg-S and O-3) modulate MRC, BALf eosinophils, eosinophilic inflammation related genes (eotaxin, CCL11 and CCL24), peribronchial and perivascular inflammation, EPO, type 2 cytokines (IL-4, 5 and 13), IgE, histamine, Cyc-LT and LTB4 as main allergic bio-factors. Importantly, Co-Q10 treatment increased Nrf2 expression and Nrf2 induced antioxidant genes, glutathione redox and inhibited inflammation, oxidative stress injury, Th2 cytokines production and attenuated allergic inflammatory responses. CONCLUSION: Nrf2 is activated in response to allergen, induces resistance against the rhinitis and asthma development and plays an essential role in broncho-protection. Co-Q10 increases the Nrf2 expression and the Nrf2 over-expression has strong effect in control of type2 cytokines, allergic mediators and inflammatory factors that lead to harnessing of allergy and asthma. GRAPHIC ABSTRACT: [Image: see text] BioMed Central 2021-03-20 /pmc/articles/PMC7980733/ /pubmed/33743807 http://dx.doi.org/10.1186/s13223-021-00534-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Du, Qixue
Meng, Wei
Athari, Seyyed Shamsadin
Wang, Renzhong
The effect of Co-Q10 on allergic rhinitis and allergic asthma
title The effect of Co-Q10 on allergic rhinitis and allergic asthma
title_full The effect of Co-Q10 on allergic rhinitis and allergic asthma
title_fullStr The effect of Co-Q10 on allergic rhinitis and allergic asthma
title_full_unstemmed The effect of Co-Q10 on allergic rhinitis and allergic asthma
title_short The effect of Co-Q10 on allergic rhinitis and allergic asthma
title_sort effect of co-q10 on allergic rhinitis and allergic asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980733/
https://www.ncbi.nlm.nih.gov/pubmed/33743807
http://dx.doi.org/10.1186/s13223-021-00534-5
work_keys_str_mv AT duqixue theeffectofcoq10onallergicrhinitisandallergicasthma
AT mengwei theeffectofcoq10onallergicrhinitisandallergicasthma
AT athariseyyedshamsadin theeffectofcoq10onallergicrhinitisandallergicasthma
AT wangrenzhong theeffectofcoq10onallergicrhinitisandallergicasthma
AT duqixue effectofcoq10onallergicrhinitisandallergicasthma
AT mengwei effectofcoq10onallergicrhinitisandallergicasthma
AT athariseyyedshamsadin effectofcoq10onallergicrhinitisandallergicasthma
AT wangrenzhong effectofcoq10onallergicrhinitisandallergicasthma